Press "Enter" to skip to content

New patent for NOVO drug OZEMPIC

0
Copyright © DrugPatentWatch. Originally published at New patent for NOVO drug OZEMPIC

Annual Drug Patent Expirations for OZEMPIC
Annual Drug Patent Expirations for OZEMPIC

Ozempic is a drug marketed by Novo and is included in one NDA. It is available from one supplier. There are eighteen patents protecting this drug.

OZEMPIC drug price trends.

Drug patent litigation for OZEMPIC.

This drug has one hundred and sixty-two patent family members in twenty-four countries.

The generic ingredient in OZEMPIC is semaglutide. One supplier is listed for this compound. Additional details are available on the semaglutide profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Copyright © DrugPatentWatch. Originally published at New patent for NOVO drug OZEMPIC
    Do NOT follow this link or you will be banned from the site!